Genalyte
Lab results in under 30 minutes, right in your clinic.
- Headquarters
- San Diego, California
- Employees
- 51–200
- Founded
- 2007
- Business Model
- B2B
- Website
- genalyte.com
- Total Funding
- $164.8M
- Last Round
- $67.0M Series CMar 2023
About
Genalyte builds point-of-care lab testing systems that deliver 90% of clinical lab results in under 30 minutes without leaving the clinic. Its flagship Merlin platform is a fully automated, onsite blood testing machine using silicon photonic microring sensor technology. The company submitted the Merlin device to the FDA for premarket clearance in 2025 and is part of the MedTech Innovator accelerator.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account